Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.
2.

Neuroplasticity and cellular resilience in mood disorders.

Manji HK, Moore GJ, Rajkowska G, Chen G.

Mol Psychiatry. 2000 Nov;5(6):578-93. Review.

PMID:
11126389
3.

The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.

Gray NA, Zhou R, Du J, Moore GJ, Manji HK.

J Clin Psychiatry. 2003;64 Suppl 5:3-17. Review.

4.

Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.

Zarate CA Jr, Du J, Quiroz J, Gray NA, Denicoff KD, Singh J, Charney DS, Manji HK.

Ann N Y Acad Sci. 2003 Nov;1003:273-91. Review.

PMID:
14684452
5.
6.
7.

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, A Gray N, Zarate CA Jr, Charney DS.

Biol Psychiatry. 2003 Apr 15;53(8):707-42. Review.

PMID:
12706957
8.

Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.

Chen G, Huang LD, Zeng WZ, K Manji H.

Int J Neuropsychopharmacol. 2001 Mar;4(1):47-64. Review.

PMID:
11343630
10.

The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.

Chen G, Manji HK.

Curr Opin Psychiatry. 2006 May;19(3):313-23. Review.

PMID:
16612219
11.

Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.

Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G.

J Clin Psychiatry. 1999;60 Suppl 2:27-39; discussion 40-1, 113-6. Review.

12.
13.

Neuronal plasticity and survival in mood disorders.

Duman RS, Malberg J, Nakagawa S, D'Sa C.

Biol Psychiatry. 2000 Oct 15;48(8):732-9.

PMID:
11063970
14.

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Bachmann RF, Schloesser RJ, Gould TD, Manji HK.

Mol Neurobiol. 2005 Oct;32(2):173-202. Review.

PMID:
16215281
16.

Finding the intracellular signaling pathways affected by mood disorder treatments.

Coyle JT, Duman RS.

Neuron. 2003 Apr 24;38(2):157-60. Review.

17.

Antidepressants and neuroplasticity.

D'Sa C, Duman RS.

Bipolar Disord. 2002 Jun;4(3):183-94. Review.

PMID:
12180273
18.

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

Manji HK, Moore GJ, Chen G.

Biol Psychiatry. 1999 Oct 1;46(7):929-40. Review.

PMID:
10509176
19.

The underlying neurobiology of bipolar disorder.

Manji HK, Quiroz JA, Payne JL, Singh J, Lopes BP, Viegas JS, Zarate CA.

World Psychiatry. 2003 Oct;2(3):136-46.

20.

Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.

Chen G, Hasanat KA, Bebchuk JM, Moore GJ, Glitz D, Manji HK.

Psychosom Med. 1999 Sep-Oct;61(5):599-617. Review.

PMID:
10511011
Items per page

Supplemental Content

Write to the Help Desk